Document:

Exhibit 10.2

 

iSpecimen
Inc.

 

first
amendment to executive employment agreement

 

This First Amendment to
Executive Employment Agreement (this “Amendment”) is made and entered into and effective as of June 20,
2022 (the “Effective Date”), by and between iSpecimen Inc., a Delaware corporation located at 450 Bedford
St, Lexington, MA 02420 (the “Company”), and Jill Mullan (the “Executive”).

 

WHEREAS,
the Company and the Executive have entered into an Executive Employment Agreement dated June 21, 2021 (the “Executive
Employment Agreement”); and

 

WHEREAS,
the Company and the Executive wish to amend the Agreement to extend the Expiration Date set forth in Section 4 of the Executive Employment
Agreement so that there is sufficient time for the Company’s board of directors and the Executive to complete the performance review
described in Section 3 of the Executive Employment Agreement for the purpose of determining the Executive’s compensation and
performance goals for the annual period through June 21, 2023; and

 

NOW,
THEREFORE, in consideration of the mutual promises and covenants set forth herein, and
for other good and valuable consideration, the receipt of and sufficiency of which are hereby acknowledged, the Company and the undersigned
Executive agree as follows:

 

1.             Defined
Terms. Except as specifically provided herein, capitalized terms not defined herein shall have the meanings ascribed to them in
the Executive Employment Agreement.

 

2.             Amendment
to Section 4 the Executive Employment Agreement. Effective as of the Effective Date, the
Company and the Executive hereby completely amend and restate Section 4 of the Executive Employment Agreement so that it reads as
follows:

 

	 	“4. 	Term. The term of this Agreement shall commence on the date first above written and shall terminate at 11:59 p.m. on
the earlier to occur of (i) July 29, 2022, (ii) the death or disability of the Executive, or (iii) the occurrence
of any of the circumstances described in Section 5 hereof (the “Expiration Date”). In the event of death
or disability, the Executive or the Executive’s estate, as applicable, shall receive payment of all unpaid or accrued salary, earned
or accrued bonuses, and the vesting of the stock or other equity participation then held by the Executive, but pro-rated until the date
of termination.”

 

3.             No
Other Amendments. Nothing in this Amendment is intended to amend any language of the Executive Employment Agreement other than
as specifically set forth above, and the remainder of the Executive Employment Agreement shall be unmodified and in full force and effect.

 

[REST OF PAGE INTENTIONALLY LEFT BLANK –
SIGNATURE PAGE FOLLOWS]

 

    
	 	iSpecimen Inc.
Page 1
Amendment to Jill Mullan Executive Employment Agreement, June 20, 2022
	

     

    

 

In
Witness Whereof, the parties hereto have executed this Amendment to the Executive Employment Agreement as of the date and
year first above written.

 

	 	Company:
	 	 
	 	iSpecimen Inc.
	 	 
	 	 
	 	By:	/s/ Christopher Ianelli
	 	 	Name:	Christopher Ianelli
	 	 	Title:	Chief Executive Officer and President

 

	Executive:	 
	 	 
	/s/ Jill Mullan	 
	Jill Mullan	 

 

    
	 	iSpecimen Inc.
Page 2
Amendment to Jill Mullan Executive Employment Agreement, June 2022Exhibit 10.3

 

iSpecimen
Inc.

 

first
amendment to executive employment agreement

 

This First Amendment to
Executive Employment Agreement (this “Amendment”) is made and entered into and effective as of June 20,
2022 (the “Effective Date”), by and between iSpecimen Inc., a Delaware corporation located at 450 Bedford
St, Lexington, MA 02420 (the “Company”), and Tracy Curley (the “Executive”).

 

WHEREAS,
the Company and the Executive have entered into an Executive Employment Agreement dated June 21, 2021 (the “Executive
Employment Agreement”); and

 

WHEREAS,
the Company and the Executive wish to amend the Agreement to extend the Expiration Date set forth in Section 4 of the Executive Employment
Agreement so that there is sufficient time for the Company’s board of directors and the Executive to complete the performance review
described in Section 3 of the Executive Employment Agreement for the purpose of determining the Executive’s compensation and
performance goals for the annual period through June 21, 2023; and

 

NOW,
THEREFORE, in consideration of the mutual promises and covenants set forth herein, and
for other good and valuable consideration, the receipt of and sufficiency of which are hereby acknowledged, the Company and the undersigned
Executive agree as follows:

 

1.              Defined
Terms. Except as specifically provided herein, capitalized terms not defined herein shall have the meanings ascribed to them in
the Executive Employment Agreement.

 

2.              Amendment
to Section 4 the Executive Employment Agreement. Effective as of the Effective Date, the
Company and the Executive hereby completely amend and restate Section 4 of the Executive Employment Agreement so that it reads as
follows:

 

	 	“4. 	Term. The term of this Agreement shall commence on the date first above written and shall terminate at 11:59 p.m. on
the earlier to occur of (i) July 29, 2022, (ii) the death or disability of the Executive, or (iii) the occurrence
of any of the circumstances described in Section 5 hereof (the “Expiration Date”). In the event of death
or disability, the Executive or the Executive’s estate, as applicable, shall receive payment of all unpaid or accrued salary, earned
or accrued bonuses, and the vesting of the stock or other equity participation then held by the Executive, but pro-rated until the date
of termination.”

 

3.              No
Other Amendments. Nothing in this Amendment is intended to amend any language of the Executive Employment Agreement other than
as specifically set forth above, and the remainder of the Executive Employment Agreement shall be unmodified and in full force and effect.

 

[REST OF PAGE INTENTIONALLY LEFT BLANK –
SIGNATURE PAGE FOLLOWS]

 

    
	 	iSpecimen Inc.
Page 1
Amendment to Tracy Curley Executive Employment Agreement, June 20, 2022
	

     

    

 

In
Witness Whereof, the parties hereto have executed this Amendment to the Executive Employment Agreement as of the date and
year first above written.

 

	 	Company:
	 	 
	 	iSpecimen Inc.
	 	 
	 	 
	 	By:	/s/ Christopher Ianelli
	 	 	Name:	Christopher Ianelli
	 	 	Title:	Chief Executive Officer and President

 

	Executive:	 
	 	 
	/s/ Tracy Curley	 
	Tracy Curley	 

 

    
	 	iSpecimen Inc.
Page 2
Amendment to Tracy Curley Executive Employment Agreement, June 2022Exhibit 10.4

 

iSpecimen
Inc.

 

first
amendment to executive employment agreement

 

This First Amendment to
Executive Employment Agreement (this “Amendment”) is made and entered into and effective as of June 20,
2022 (the “Effective Date”), by and between iSpecimen Inc., a Delaware corporation located at 450 Bedford
St, Lexington, MA 02420 (the “Company”), and Benjamin Bielak (the “Executive”).

 

WHEREAS,
the Company and the Executive have entered into an Executive Employment Agreement dated June 21, 2021 (the “Executive
Employment Agreement”); and

 

WHEREAS,
the Company and the Executive wish to amend the Agreement to extend the Expiration Date set forth in Section 4 of the Executive Employment
Agreement so that there is sufficient time for the Company’s board of directors and the Executive to complete the performance review
described in Section 3 of the Executive Employment Agreement for the purpose of determining the Executive’s compensation and
performance goals for the annual period through June 21, 2023; and

 

NOW,
THEREFORE, in consideration of the mutual promises and covenants set forth herein, and
for other good and valuable consideration, the receipt of and sufficiency of which are hereby acknowledged, the Company and the undersigned
Executive agree as follows:

 

1.              Defined
Terms. Except as specifically provided herein, capitalized terms not defined herein shall have the meanings ascribed to them in
the Executive Employment Agreement.

 

2.              Amendment
to Section 4 the Executive Employment Agreement. Effective as of the Effective Date, the
Company and the Executive hereby completely amend and restate Section 4 of the Executive Employment Agreement so that it reads as
follows:

 

“4.           Term.
The term of this Agreement shall commence on the date first above written and shall terminate at 11:59 p.m. on the earlier to
occur of (i) July 29, 2022, (ii) the death or disability of the Executive, or (iii) the occurrence of any of the circumstances
described in Section 5 hereof (the “Expiration Date”). In the event of death or disability, the Executive
or the Executive’s estate, as applicable, shall receive payment of all unpaid or accrued salary, earned or accrued bonuses, and
the vesting of the stock or other equity participation then held by the Executive, but pro-rated until the date of termination.”

 

3.              No
Other Amendments. Nothing in this Amendment is intended to amend any language of the Executive Employment Agreement other than
as specifically set forth above, and the remainder of the Executive Employment Agreement shall be unmodified and in full force and effect.

 

[REST OF PAGE INTENTIONALLY LEFT BLANK –
SIGNATURE PAGE FOLLOWS]

 

    iSpecimen Inc.
Page 1
Amendment to Benjamin
                                                                                                                                                                                                                                                                                                                                                                                                                              Bielak Executive Employment Agreement, June 20, 2022 

     

    

 

In
Witness Whereof, the parties hereto have executed this Amendment to the Executive Employment Agreement as of the date and
year first above written.

 

	 	Company:
	 	 
	 	
    iSpecimen
Inc. 

	 	 
	 	 
	 	By:	/s/ Christopher Ianelli
	 	 	Name:	Christopher Ianelli
	 	 	Title:	Chief Executive Officer and President
	 	 	 	 

 

Executive:

 

 

	/s/ Benjamin Bielak 	 
	Benjamin Bielak	 

 

    iSpecimen Inc.
Page 2
Amendment to Benjamin Bielak Executive Employment Agreement, June 2022

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}]]